Roivant Sciences Investments Fair Value Disclosure decreased by 6.0% to $407.99M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.7%, from $302.94M to $407.99M. Over 5 years (FY 2020 to FY 2025), Investments Fair Value Disclosure shows an upward trend with a 16.6% CAGR.
other_investments_fair_value_disclosure| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.36M | $436.78M | $398.74M | $325.83M | $301.29M | $246.61M | $272.47M | $304.32M | $296.24M | $250.39M | $239.93M | $247.75M | $262.98M | $311.35M | $290.04M | $302.94M | $283.81M | $412.32M | $433.91M | $407.99M |
| QoQ Change | — | +142.2% | -8.7% | -18.3% | -7.5% | -18.1% | +10.5% | +11.7% | -2.7% | -15.5% | -4.2% | +3.3% | +6.1% | +18.4% | -6.8% | +4.4% | -6.3% | +45.3% | +5.2% | -6.0% |
| YoY Change | — | — | — | — | +67.0% | -43.5% | -31.7% | -6.6% | -1.7% | +1.5% | -11.9% | -18.6% | -11.2% | +24.3% | +20.9% | +22.3% | +7.9% | +32.4% | +49.6% | +34.7% |